Literature DB >> 11499644

T1 hypointensity of the spinal cord in multiple sclerosis.

N A Losseff1, L Wang, D H Miller, A J Thompson.   

Abstract

It has recently been shown in multiple sclerosis (MS) that the volume of T1 hypointense lesions in the brain explains more of the variance in disability amongst patients than T2 lesion volume. T1 hypointense lesions may therefore represent areas of underlying pathology likely to be of functional significance, such as axonal loss. The spinal cord is a common area of involvement in MS and its dysfunction is likely to be responsible for much of the motor disability seen. Hence it serves as a useful model by which to examine the functional relevance of differing imaging sequences. We have therefore examined the relationship between T1 signal intensity in the spinal cord and disability in 60 patients with MS. We have also examined the relationship between T1 signal intensity and atrophy of the cord, as the latter is another potential marker of axonal loss. Sixty patients with MS underwent spinal cord imaging with a T1 weighted sequence to acquire axial sections of the cord at the C2 level. These sections were histogram matched to allow comparison of image intensity and a manual outlining technique was applied from which the mean cord intensity was calculated. Within the patient group there was a significant relationship between T1 signal intensity and disability as measured with the EDSS (r = -0.4, p < 0.005) and also between T1 signal intensity and atrophy (r = 0.36, p < 0.005). This study demonstrates that disability and atrophy are associated with a generalised reduction in cord signal on T1 weighted images. A lower T1 signal intensity in the spinal cord may be more pathologically specific than T2 hyperintensity and may represent underlying axonal loss, although gliosis and predominant white matter atrophy are alternative possibilities.

Entities:  

Mesh:

Year:  2001        PMID: 11499644     DOI: 10.1007/s004150170163

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.

Authors:  M Nakamura; I Miyazawa; K Fujihara; I Nakashima; T Misu; S Watanabe; T Takahashi; Y Itoyama
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

2.  Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.

Authors:  Raffaele Iorio; Valentina Damato; Massimiliano Mirabella; Amelia Evoli; Alessandro Marti; Domenico Plantone; Giovanni Frisullo; Anna Paola Batocchi
Journal:  J Neurol       Date:  2013-06-21       Impact factor: 4.849

3.  Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?

Authors:  Jonathan James Downer; Maria Isabel Leite; Ranjana Carter; Jacqueline Palace; Wilhelm Küker; Gerardine Quaghebeur
Journal:  Neuroradiology       Date:  2011-05-07       Impact factor: 2.804

4.  Neuroradiological evaluation of demyelinating disease.

Authors:  Jan-Mendelt Tillema; Istvan Pirko
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

5.  Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.

Authors:  Su Hyun Kim; Sung Min Kim; Angela Vincent; Suk Won Ahn; Yoon Ho Hong; Kyung Seok Park; Jung Joon Sung; Kwang Woo Lee
Journal:  J Neurol       Date:  2010-01-06       Impact factor: 4.849

6.  Contrasting roles for CD4 vs. CD8 T-cells in a murine model of virally induced "T1 black hole" formation.

Authors:  Istvan Pirko; Yi Chen; Anne K Lohrey; Jeremiah McDole; Jeffrey D Gamez; Kathleen S Allen; Kevin D Pavelko; Diana M Lindquist; R Scott Dunn; Slobodan I Macura; Aaron J Johnson
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

7.  Pre-contrast T1-weighted imaging of the spinal cord may be unnecessary in patients with multiple sclerosis.

Authors:  Nico Sollmann; Jan S Kirschke; Isabelle Riederer; Mark Mühlau; Claus Zimmer; Magaly Gutbrod-Fernandez
Journal:  Eur Radiol       Date:  2021-06-09       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.